Valuation dashboard for Sotera Health Company (SHC) with P/E 32.36, P/B 7.96, EV/EBITDA 13.35 and dividend yield 0.00%. DCF, Graham Number, EPS growth, peer multiples and dividend discount models plus sector comparison against other Healthcare companies.
Sotera Health Company, headquartered in Broadview Heights, Ohio, delivers essential sterilization, laboratory testing, and advisory services to a global clientele spanning North America, Europe, and various international regions. The firm's sterilization capabilities encompass gamma and electron beam irradiation, alongside ethylene oxide (EO) processing. Through its Nelson Labs division, Sotera Health conducts comprehensive microbiological and analytical chemistry analyses.
Analysis Summary
Sotera Health Company reported revenue of $1.16B in the most recent fiscal year, growing at a 5-year CAGR of 7.3%.
Trailing-twelve-month margins: gross margin 54.7%, operating margin 36.2%, net margin 13.4%.
At the current price of $18.55, SHC trades at a P/E of 32.36 and an ROE of 26.75%. Market capitalisation stands at $5.3B.
Balance sheet quality for SHC: current ratio of 2.5. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| P/E Ratio | 32.36 |
| Price / Book | 7.96 |
| EV / EBITDA | 13.35 |
| Dividend Yield | 0.00% |
Valuation Models
| DCF Fair Value | $-2.07 |
| vs Current Price | -111.2% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| SHC | Sotera Health Company | $5.3B | 32.36 | 7.96 | 26.7% |
| ACLX | Arcellx, Inc. | $6.7B | 16.10 | -56.9% | |
| PTGX | Protagonist Therapeutics, Inc. | $9.2B | 114.98 | 10.97 | -21.2% |
| ALKS | Alkermes plc | $6.7B | 106.10 | 3.94 | 3.7% |
| OPCH | Option Care Health, Inc. | $3.4B | 17.02 | 2.78 | 15.7% |
| MMSI | Merit Medical Systems, Inc. | $5.1B | 40.62 | 3.29 | 8.1% |
| GKOS | Glaukos Corporation | $9.4B | 14.02 | -28.6% | |
| BLCO | Bausch + Lomb Corporation | $6.1B | 0.96 | -2.7% |
Price
| Price | $18.55 |
| Market Cap | $5.3B |
| Exchange | NASDAQ |
| Country | US |
Profitability
| Return on Equity | 26.75% |
| Return on Invested Capital | 8.80% |
| Return on Assets | 4.94% |
| Gross Margin | 54.72% |
| Operating Margin | 36.24% |
| Net Margin | 13.44% |
Related companies: ALKS · BLCO · GKOS · MMSI · OPCH · OSCR
Explore sector: Healthcare · Medical - Diagnostics & Research
More sections of SHC: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks